Sung, H. et al. World Most cancers Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 nations. CA Most cancers J. Clin. 71, 209–249 (2021).
Canadian Most cancers Statistics: A 2020 Particular Report on Lung Most cancers (Canadian Most cancers Society, 2020); https://cdn.most cancers.ca/-/media/information/cancer-information/sources/publications/2020-canadian-cancer-statistics-special-report/2020-canadian-cancer-statistics-special-report-en.pdf
Aberle, D. R. et al. Diminished lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395–409 (2011).
de Koning, H. J. et al. Diminished lung-cancer mortality with quantity CT screening in a randomized trial. N. Engl. J. Med. 382, 503–513 (2020).
Moyer, V. A. & U.S. Preventive Companies Process Pressure.Screening for lung most cancers: U.S. Preventive Companies Process Pressure advice assertion. Ann. Intern. Med. 160, 330–338 (2014).
Screening for Lung Most cancers with Low Dose Computed Tomography (LDCT) (CAG-00439N) (Facilities for Medicare & Medicaid Companies, 2015); https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=274
The US nationwide lung most cancers screening programme. Lung Most cancers Coverage Community https://www.lungcancerpolicynetwork.com/the-us-national-lung-cancer-screening-programme/ (2022).
Interactive map of lung most cancers screening. Lung Most cancers Coverage Community https://www.lungcancerpolicynetwork.com/now-available-interactive-map-of-lung-cancer-screening-implementation/ (2022).
Schneider, E. et al. Mirror, mirror 2021: reflecting poorly—well being care within the U.S. in comparison with different high-income nations. The Commonwealth Fund https://www.commonwealthfund.org/publications/fund-reports/2021/aug/mirror-mirror-2021-reflecting-poorly (2021).
Ivers, N., Brown, A. D. & Detsky, A. S. Classes from the Canadian expertise with single-payer medical insurance: simply snug sufficient with the established order. JAMA Intern. Med. 178, 1250–1255 (2018).
de Koning, H. J. et al. Diminished lung-cancer mortality with quantity CT screening in a randomized trial. N. Engl. J. Med. 382, 503–513 (2020).
Mazzone, P. J., White, C. S., Kazerooni, E. A., Smith, R. A. & Thomson, C. C. Proposed high quality metrics for lung most cancers screening packages: a Nationwide Lung Most cancers Roundtable undertaking. Chest 160, 368–378 (2021).
Candal-Pedreira, C., Ruano-Ravina, A., Provencio, M., Fernandez-Villar, A. & Perez-Rios, M. Lung most cancers screening high quality standards: a inhabitants perspective. Chest 160, e329–e331 (2021).
Canadian Partnership Towards Most cancers & Pan-Canadian Lung Most cancers Screening Community. Nationwide Lung Most cancers Screening High quality Indicators Report, 1st edn (Canadian Partnership Towards Most cancers, 2017).
Martin, D. et al. Canada’s common health-care system: attaining its potential. Lancet 391, 1718–1735 (2018).
Ellison L. F. & Saint-Jacques N. 5-year most cancers survival by stage at analysis in Canada. Well being Rep. 34, 3–15 (2023).
Wait Instances (Ontario Well being, 2021); https://www.ontariohealth.ca/public-reporting/wait-times
Habbous, S. et al. The impact of diagnostic evaluation packages on the analysis and therapy of sufferers with lung most cancers in Ontario, Canada. Ann. Thorac. Med. 16, 81–101 (2021).
Elrod, J. Okay. & Fortenberry, J. L. Jr. The hub-and-spoke group design: an avenue for serving sufferers nicely. BMC Well being Serv. Res. 17, 457 (2017).
Kucharczyk, M. J., Menezes, R. J., McGregor, A., Paul, N. S. & Roberts, H. C. Assessing the influence of incidental findings in a lung most cancers screening research by utilizing low-dose computed tomography. Can. Assoc. Radio. J. 62, 141–145 (2011).
Regis, S. M. et al. Outcomes of constructive and suspicious findings in scientific computed tomography lung most cancers screening and the highway forward. Ann. Am. Thorac. Soc. 19, 1371–1378 (2022).
Lopez-Olivo, M. A. et al. Affected person adherence to screening for lung most cancers within the US: a scientific assessment and meta-analysis. JAMA Netw. Open 3, e2025102 (2020).
Subject, J. Okay. et al. The UK Lung Most cancers Screening Trial: a pilot randomised managed trial of low-dose computed tomography screening for the early detection of lung most cancers. Well being Technol. Assess. 20, 1–146 (2016).
Jonas, D. E. et al. Screening for lung most cancers with low-dose computed tomography: up to date proof report and systematic assessment for the US Preventive Companies Process Pressure. JAMA 325, 971–987 (2021).
Bach, P. B. et al. Advantages and harms of CT screening for lung most cancers: a scientific assessment. JAMA 307, 2418–2429 (2012).
Tammemagi, M. C. et al. Choice of people for lung most cancers screening based mostly on threat prediction mannequin efficiency and financial elements—the Ontario expertise. Lung Most cancers 156, 31–40 (2021).
Slatore, C. G., Sullivan, D. R., Pappas, M. & Humphrey, L. L. Affected person-centered outcomes amongst lung most cancers screening recipients with computed tomography: a scientific assessment. J. Thorac. Oncol. 9, 927–934 (2014).
Ten Haaf, Okay. et al. Efficiency and cost-effectiveness of computed tomography lung most cancers screening situations in a population-based setting: a microsimulation modeling evaluation in Ontario, Canada. PLoS Med. 14, e1002225 (2017).
Huo, Y. R., Chan, M. V., Habib, A. R., Lui, I. & Ridley, L. Pneumothorax charges in CT-guided lung biopsies: a complete systematic assessment and meta-analysis of threat elements. Br. J. Radiol. 93, 20190866 (2020).
Indigenous Peoples in Ontario (Ministry of Indigenous Affairs, 2018); https://www.ontario.ca/doc/spirit-reconciliation-ministry-indigenous-relations-and-reconciliation-first-10-years/indigenous-peoples-ontario
Chiefs of Ontario and Most cancers Care Ontario. Most cancers in First Nations in Ontario: Danger Components and Screening. https://www.cancercareontario.ca/en/statistical-reports/cancer-first-nations-ontario-risk-factors-and-screening-report (2017).
Focused Screening for Lung Most cancers with Low Radiation Dose Computed Tomography: Commonplace Protocol Ready for the Focused Lung Well being Checks Programme (NHS England, 2019); https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/
Allemani, C. et al. World surveillance of developments in most cancers survival 2000–14 (CONCORD-3): evaluation of particular person information for 37 513 025 sufferers identified with one among 18 cancers from 322 population-based registries in 71 nations. Lancet 391, 1023–1075 (2018).
Arnold, M. et al. Progress in most cancers survival, mortality, and incidence in seven high-income nations 1995–2014 (ICBP SURVMARK-2): a population-based research. Lancet Oncol. 20, 1493–1505 (2019).
Rivera, M. P. et al. Receipt of advisable follow-up care after a constructive lung most cancers screening examination. JAMA Netw. Open 5, e2240403 (2022).
Nationwide Lung Screening Trial Analysis Trial. Outcomes of preliminary low-dose computed tomographic screening for lung most cancers. N. Engl. J. Med. 368, 1980–1991 (2013).
Aberle, D. R. et al. Outcomes of the 2 incidence screenings within the Nationwide Lung Screening Trial. N. Engl. J. Med. 369, 920–931 (2013).
Pinsky, P. F. et al. Efficiency of Lung-RADS within the Nationwide Lung Screening Trial: a retrospective evaluation. Ann. Intern. Med. 162, 485–491 (2015).
Ontario Lung Screening Program Places (Ontario Well being (Most cancers Care Ontario), 2020); https://www.cancercareontario.ca/en/find-cancer-services/ontario-lung-screening-program-locations
Darling, G. E. et al. Organized lung most cancers screening pilot: informing a province-wide program in Ontario, Canada. Ann. Thorac. Surg. 111, 1805–1811 (2021).
Lung Screening Referral Kind (Ontario Well being (Most cancers Care Ontario), 2020); https://www.cancercareontario.ca/websites/ccocancercare/information/property/LungCancerScreening_ReferralForm.pdf
Tammemagi, M. C. et al. Choice standards for lung-cancer screening. N. Engl. J. Med. 368, 728–736 (2013).
Evans, W. Okay. et al. Integrating smoking cessation into low-dose computed tomography lung most cancers screening: outcomes of the Ontario, Canada pilot. J. Thorac. Oncol. 18, 1323–1333 (2023).
Lung CT Screening Reporting and Knowledge System (Lung-RADS) (American Faculty of Radiology, 2019); https://www.acr.org/Medical-Assets/Reporting-and-Knowledge-Techniques/Lung-Rads
Lung-RADS® v2022 (American Faculty of Radiology, 2022); https://www.acr.org/-/media/ACR/Information/RADS/Lung-RADS/Lung-RADS-2022.pdf
Lung-RADS® v2022. Abstract of Adjustments and Updates (American Faculty of Radiology, 2022); https://www.acr.org/-/media/ACR/Information/RADS/Lung-RADS/Lung-RADS-2022-Abstract-_Final.pdf
Radiology High quality Assurance Program Handbook–Ontario Lung Screening Program (Ontario Well being (Most cancers Care Ontario), 2021); https://www.cancercareontario.ca/websites/ccocancercare/information/property/RadiologyQualityAssuranceProgramManual.pdf
Darling, G. E. et al. Organized lung most cancers screening pilot: informing a province-wide program in Ontario, Canada. Ann. Thorac. Surg. 111, 1805–1811 (2021).
